Literature DB >> 20443863

Pharmacotherapy and pregnancy: Highlights from the first International Conference for Individualized Pharmacotherapy in Pregnancy.

David M Haas1, Jamie L Renbarger, Scott Denne, Mahmoud S Ahmed, Thomas Easterling, Karen Feibus, Eric M Meslin, Gideon Koren, Anne Zajicek, Wayne R Snodgrass, David A Flockhart.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20443863      PMCID： PMC5350789          DOI： 10.1111/j.1752-8062.2009.00079.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  14 in total

Review 1.  Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.

Authors:  Tommy Andersson; David A Flockhart; David B Goldstein; Shiew-Mei Huang; Deanna L Kroetz; Patrice M Milos; Mark J Ratain; Kenneth Thummel
Journal:  Clin Pharmacol Ther       Date:  2005-12       Impact factor: 6.875

2.  10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes.

Authors:  P Dalén; M L Dahl; M L Bernal Ruiz; J Nordin; L Bertilsson
Journal:  Clin Pharmacol Ther       Date:  1998-04       Impact factor: 6.875

3.  Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons.

Authors:  Selvan Ravindran; Olga L Zharikova; Ronald A Hill; Tatiana N Nanovskaya; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2006-08-30       Impact factor: 5.858

4.  Ethics and clinical research.

Authors:  H K Beecher
Journal:  N Engl J Med       Date:  1966-06-16       Impact factor: 91.245

5.  Second-line treatment of fetal supraventricular tachycardia using flecainide acetate.

Authors:  E S Ebenroth; T M Cordes; R K Darragh
Journal:  Pediatr Cardiol       Date:  2001-12-04       Impact factor: 1.655

6.  Sample bias among women with retained DNA samples for future genetic studies.

Authors:  Kjersti Aagaard-Tillery; Baha Sibai; Catherine Y Spong; Valerija Momirova; George Wendel; Katharine Wenstrom; Philip Samuels; Margaret Cotroneo; Atef Moawad; Yoram Sorokin; Menachem Miodovnik; Paul Meis; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner
Journal:  Obstet Gynecol       Date:  2006-11       Impact factor: 7.661

7.  Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester.

Authors:  G Koren; M Bologa; D Long; Y Feldman; N H Shear
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

8.  Bendectin and birth defects. II: Ecological analyses.

Authors:  Jeffrey S Kutcher; Arnold Engle; Jacqueline Firth; Steven H Lamm
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-02

9.  Patient attitudes toward genotyping in an urban women's health clinic.

Authors:  David M Haas; Jamie L Renbarger; Eric M Meslin; Katherine Drabiak; David Flockhart
Journal:  Obstet Gynecol       Date:  2008-11       Impact factor: 7.661

10.  Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study.

Authors:  M F Hebert; T R Easterling; B Kirby; D B Carr; M L Buchanan; T Rutherford; K E Thummel; D P Fishbein; J D Unadkat
Journal:  Clin Pharmacol Ther       Date:  2008-02-20       Impact factor: 6.903
View more
  1 in total

1.  Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.

Authors:  David M Haas; Mary F Hebert; Offie P Soldin; David A Flockhart; Parvaz Madadi; James J Nocon; Christina D Chambers; Gary D Hankins; Shannon Clark; Katherine L Wisner; Lang Li; Jamie L Renbarger; Lee A Learman
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.